Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
Université Paris Cité · Inserm · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
984
total citations
- FWCI
- 140.98
- Percentile
- 100%
- References
- 33
Citations per year
Authors
19- AMAlexandre MebazaaCorresponding
Université Paris Cité, Inserm, Hôpital Lariboisière, Assistance Publique – Hôpitaux de Paris
- BABeth A. Davison
Momentum Research, Inserm, Université Paris Cité
- OCOvidiu Chioncel
Carol Davila University of Medicine and Pharmacy
- ACAlain Cohen‐Solal
Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Inserm, Université Paris Cité
- RDRafael Díaz
Estudios Clínicos Latinoamérica, Instituto Cardiovascular de Rosario
Topics & keywords
Topics
Keywords
- Tolerability
- Medicine
- Guideline
- Heart failure
- Open label
- Intensive care medicine
- Randomized controlled trial
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.